August 22, 2019

Silverstein v. Boehringer Ingelheim Pharmaceuticals, Inc.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. August 05, 2020

    Boehringer Dodges Sanctions In Florida Pradaxa Disputes

    Judges in two Florida federal courts have turned down bids to sanction Boehringer Ingelheim Pharmaceuticals Inc. over evidence it allegedly failed to preserve in suits over the anticoagulant Pradaxa, with both judges saying the company can't be sanctioned for actions taken by its predecessor.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS